The Cooper Companies Acquires Sauflon Pharmaceuticals

Acquisition gives CooperVision the world's most comprehensive portfolio of daily disposable lenses

July 02, 2014

The Cooper Companies, Inc. (NYSE: COO) has announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals Ltd, a European manufacturer and distributor of soft contact lenses and solutions, in a transaction valued at approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 21% year-over-year. The transaction is subject to regulatory approval and is anticipated to close prior to fiscal year end, October 31, 2014.

Latham & Watkins represents The Cooper Companies in the transaction with a London-based team led by corporate partner Graeme Ward, with corporate associates Andrew Clark and Warren Fernandez. Advice has also been provided on US law matters by Silicon Valley partner Kit Kaufman; on tax matters by partner Sean Finn and associate Sinthubiravi Sivakumaran; and on employment matters by partner Stephen Brown and associates Sarah Gadd and Kendall Burnett.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.